Jounce Therapeutics and Redx Pharma Terminate Proposed Merger
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest analyst downgrades you may have missed since yesterday.Marathon Petroleum downgraded at...
Jounce Therapeutics (JNCE) Halted, News Pending
We expect investors to focus on pipeline updates when Jounce Therapeutics, Inc. (NASDAQ:JNCE) reports fourth-quarter 2019 results.Shares of the company have gained 43.7% in the...
ImmunoGen, Inc. (NASDAQ:IMGN) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares...
The U.S. economy has witnessed several ups and downs this year. While weak global economic growth outlook weighed on the stocks, federal measures like rate cuts boosted the...
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. It develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. The company is also developing JTX-8064, a monoclonal antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and Pimivalimab, an anti-PD-1 antibody for combination therapy. In addition, its preclinical products are JTX-1484, a monoclonal antibody designed to reduce myeloid-mediated immune suppression; and JTX-2134, a monoclonal antibody designed to reduce myeloid-mediated immune suppression and activate T and NK cells. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. As of May 3, 2023, Jounce Therapeutics, Inc. operates as a subsidiary of Concentra Biosciences, LLC.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.95 | 8.75 | 7.79 | +0.15 | +1.99% | 88.33M | NYSE | |||
| 123.50 | 124.29 | 122.42 | +0.83 | +0.68% | 7.28M | NASDAQ | |||
| 138.65 | 139.61 | 137.41 | -0.25 | -0.18% | 100.45K | NYSE | |||
| 72.33 | 74.91 | 70.60 | +3.23 | +4.67% | 6.62M | NASDAQ | |||
| 23.38 | 27.30 | 23.05 | -0.85 | -3.51% | 40.30M | NYSE | |||
| 135.09 | 137.00 | 134.36 | +1.69 | +1.27% | 614.16K | NASDAQ | |||
| 0.39 | 0.3998 | 0.3201 | +0.0500 | +14.71% | 133.04K | NASDAQ | |||
| 57.03 | 64.69 | 56.57 | -1.45 | -2.48% | 16.44M | NASDAQ | |||
| 5.125 | 5.74 | 4.90 | +0.4350 | +9.28% | 1.80M | NASDAQ | |||
| 14.00 | 14.00 | 14.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 14.98 | 15.32 | 14.85 | -0.22 | -1.48% | 2.10M | NYSE | |||
| 10.42 | 10.58 | 10.13 | +0.38 | +3.80% | 8.76M | NYSE | |||
| 108.66 | 109.98 | 106.00 | +1.87 | +1.75% | 132.15K | NASDAQ | |||
| 32.34 | 32.45 | 30.74 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 92.06 | 92.92 | 91.93 | -0.47 | -0.51% | 2.94M | NYSE |